PubMed:10373522
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 960-969 | DiseaseOrPhenotypicFeature | denotes | sensitive | 0000605 |
| T2 | 1361-1370 | DiseaseOrPhenotypicFeature | denotes | sensitive | 0000605 |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-8 | protein | denotes | p70(s6k) |
| T2 | 20-49 | protein | denotes | phosphatidylinositol 3-kinase |
| T3 | 86-89 | protein | denotes | E2F |
| T4 | 104-117 | cell_type | denotes | T lymphocytes |
| T5 | 122-135 | cell_type | denotes | T lymphocytes |
| T6 | 141-163 | protein | denotes | hematopoietic cytokine |
| T7 | 164-177 | protein | denotes | interleukin-2 |
| T8 | 179-183 | protein | denotes | IL-2 |
| T9 | 190-219 | protein | denotes | phosphatidylinositol 3-kinase |
| T10 | 221-232 | protein | denotes | PI 3-kinase |
| T11 | 273-276 | protein | denotes | E2F |
| T12 | 337-348 | protein | denotes | PI 3-kinase |
| T13 | 380-388 | protein | denotes | p70(s6k) |
| T14 | 394-425 | protein | denotes | 40S ribosomal protein S6 kinase |
| T15 | 711-719 | protein | denotes | p70(s6k) |
| T16 | 724-728 | protein | denotes | IL-2 |
| T17 | 733-744 | protein | denotes | PI 3-kinase |
| T18 | 759-763 | protein | denotes | E2Fs |
| T19 | 823-827 | protein | denotes | IL-2 |
| T20 | 833-844 | protein | denotes | PI 3-kinase |
| T21 | 884-887 | protein | denotes | E2F |
| T22 | 998-1024 | protein | denotes | rapamycin-resistant mutant |
| T23 | 1028-1036 | protein | denotes | p70(s6k) |
| T24 | 1040-1047 | cell_type | denotes | T cells |
| T25 | 1083-1086 | protein | denotes | E2F |
| T26 | 1151-1154 | protein | denotes | E2F |
| T27 | 1191-1199 | protein | denotes | p70(s6k) |
| T28 | 1214-1242 | protein | denotes | rapamycin-resistant p70(s6k) |
| T29 | 1459-1467 | protein | denotes | p70(s6k) |
| T30 | 1488-1491 | protein | denotes | E2F |
| T31 | 1583-1587 | protein | denotes | IL-2 |
| T32 | 1599-1610 | protein | denotes | PI 3-kinase |
| T33 | 1616-1624 | protein | denotes | p70(s6k) |
| T34 | 1667-1680 | cell_type | denotes | T lymphocytes |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-118 | Sentence | denotes | p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. |
| S2 | 119-336 | Sentence | denotes | In T lymphocytes, the hematopoietic cytokine interleukin-2 (IL-2) uses phosphatidylinositol 3-kinase (PI 3-kinase)-induced signaling pathways to regulate E2F transcriptional activity, a critical cell cycle checkpoint. |
| S3 | 337-483 | Sentence | denotes | PI 3-kinase also regulates the activity of p70(s6k), the 40S ribosomal protein S6 kinase, a response that is abrogated by the macrolide rapamycin. |
| S4 | 484-655 | Sentence | denotes | This immunosuppressive drug is known to prevent T-cell proliferation, but the precise point at which rapamycin regulates T-cell cycle progression has yet to be elucidated. |
| S5 | 656-792 | Sentence | denotes | Moreover, the effects of rapamycin on, and the role of p70(s6k) in, IL-2 and PI 3-kinase activation of E2Fs have not been characterized. |
| S6 | 793-981 | Sentence | denotes | Our present results show that IL-2- and PI 3-kinase-induced pathways for the regulation of E2F transcriptional activity include both rapamycin-resistant and rapamycin-sensitive components. |
| S7 | 982-1097 | Sentence | denotes | Expression of a rapamycin-resistant mutant of p70(s6k) in T cells could restore rapamycin-suppressed E2F responses. |
| S8 | 1098-1200 | Sentence | denotes | Thus, the rapamycin-controlled processes involved in E2F regulation appear to be mediated by p70(s6k). |
| S9 | 1201-1423 | Sentence | denotes | However, the rapamycin-resistant p70(s6k) could not rescue rapamycin inhibition of T-cell cycle entry, consistent with the involvement of additional, rapamycin-sensitive pathways in the control of T-cell cycle progression. |
| S10 | 1424-1681 | Sentence | denotes | The present results thus show that p70(s6k) is able to regulate E2F transcriptional activity and provide direct evidence for the first time for a link between IL-2 receptors, PI 3-kinase, and p70(s6k) that regulates a crucial G1 checkpoint in T lymphocytes. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-8 | NP | denotes | p70(s6k) |
| C2 | 20-49 | NP | denotes | phosphatidylinositol 3-kinase |
| C3 | 86-100 | NP | denotes | E2F regulation |
| C4 | 104-117 | NP | denotes | T lymphocytes |
| C5 | 122-135 | NP | denotes | T lymphocytes |
| C6 | 273-301 | NP | denotes | E2F transcriptional activity |
| C7 | 303-335 | NP | denotes | a critical cell cycle checkpoint |
| C8 | 337-348 | NP | denotes | PI 3-kinase |
| C9 | 380-388 | NP | denotes | p70(s6k) |
| C10 | 390-425 | NP | denotes | the 40S ribosomal protein S6 kinase |
| C11 | 427-437 | NP | denotes | a response |
| C12 | 438-442 | NP | denotes | that |
| C13 | 459-482 | NP | denotes | the macrolide rapamycin |
| C14 | 484-511 | NP | denotes | This immunosuppressive drug |
| C15 | 558-575 | NP | denotes | the precise point |
| C16 | 579-584 | NP | denotes | which |
| C17 | 585-594 | NP | denotes | rapamycin |
| C18 | 605-629 | NP | denotes | T-cell cycle progression |
| C19 | 681-690 | NP | denotes | rapamycin |
| C20 | 711-719 | NP | denotes | p70(s6k) |
| C22 | 884-912 | NP | denotes | E2F transcriptional activity |
| C21 | 866-912 | NP | denotes | the regulation of E2F transcriptional activity |
| C23 | 1028-1036 | NP | denotes | p70(s6k) |
| C24 | 1040-1047 | NP | denotes | T cells |
| C25 | 1151-1165 | NP | denotes | E2F regulation |
| C26 | 1191-1199 | NP | denotes | p70(s6k) |
| C27 | 1398-1422 | NP | denotes | T-cell cycle progression |
| C28 | 1459-1467 | NP | denotes | p70(s6k) |
| C29 | 1488-1516 | NP | denotes | E2F transcriptional activity |
| C31 | 1599-1610 | NP | denotes | PI 3-kinase |
| C32 | 1616-1624 | NP | denotes | p70(s6k) |
| C30 | 1568-1624 | NP | denotes | a link between IL-2 receptors, PI 3-kinase, and p70(s6k) |
| C33 | 1625-1629 | NP | denotes | that |
| C34 | 1667-1680 | NP | denotes | T lymphocytes |
| R1 | C5 | C4 | coref-ident | T lymphocytes,T lymphocytes |
| R2 | C7 | C6 | coref-appos | a critical cell cycle checkpoint,E2F transcriptional activity |
| R3 | C8 | C2 | coref-ident | PI 3-kinase,phosphatidylinositol 3-kinase |
| R4 | C9 | C1 | coref-ident | p70(s6k),p70(s6k) |
| R5 | C10 | C9 | coref-appos | the 40S ribosomal protein S6 kinase,p70(s6k) |
| R6 | C12 | C11 | coref-relat | that,a response |
| R7 | C14 | C13 | coref-ident | This immunosuppressive drug,the macrolide rapamycin |
| R8 | C16 | C15 | coref-relat | which,the precise point |
| R9 | C17 | C14 | coref-ident | rapamycin,This immunosuppressive drug |
| R10 | C19 | C17 | coref-ident | rapamycin,rapamycin |
| R11 | C20 | C9 | coref-ident | p70(s6k),p70(s6k) |
| R12 | C22 | C6 | coref-ident | E2F transcriptional activity,E2F transcriptional activity |
| R13 | C21 | C3 | coref-ident | the regulation of E2F transcriptional activity,E2F regulation |
| R14 | C23 | C20 | coref-ident | p70(s6k),p70(s6k) |
| R15 | C24 | C5 | coref-ident | T cells,T lymphocytes |
| R16 | C25 | C21 | coref-ident | E2F regulation,the regulation of E2F transcriptional activity |
| R17 | C26 | C23 | coref-ident | p70(s6k),p70(s6k) |
| R18 | C27 | C18 | coref-ident | T-cell cycle progression,T-cell cycle progression |
| R19 | C28 | C26 | coref-ident | p70(s6k),p70(s6k) |
| R20 | C29 | C22 | coref-ident | E2F transcriptional activity,E2F transcriptional activity |
| R21 | C31 | C8 | coref-ident | PI 3-kinase,PI 3-kinase |
| R22 | C32 | C28 | coref-ident | p70(s6k),p70(s6k) |
| R23 | C33 | C30 | coref-relat | that,"a link between IL-2 receptors, PI 3-kinase, and p70(s6k)" |
| R24 | C34 | C24 | coref-ident | T lymphocytes,T cells |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-8 | protein_molecule | denotes | p70(s6k) |
| T2 | 20-49 | protein_molecule | denotes | phosphatidylinositol 3-kinase |
| T3 | 54-81 | other_name | denotes | rapamycin-regulated signals |
| T4 | 86-89 | protein_molecule | denotes | E2F |
| T5 | 104-117 | cell_type | denotes | T lymphocytes |
| T6 | 122-135 | cell_type | denotes | T lymphocytes |
| T7 | 141-163 | protein_family_or_group | denotes | hematopoietic cytokine |
| T8 | 164-177 | protein_molecule | denotes | interleukin-2 |
| T9 | 179-183 | protein_molecule | denotes | IL-2 |
| T10 | 190-219 | protein_molecule | denotes | phosphatidylinositol 3-kinase |
| T11 | 221-232 | protein_molecule | denotes | PI 3-kinase |
| T12 | 273-276 | protein_molecule | denotes | E2F |
| T13 | 314-335 | other_name | denotes | cell cycle checkpoint |
| T14 | 337-348 | protein_molecule | denotes | PI 3-kinase |
| T15 | 380-388 | protein_molecule | denotes | p70(s6k) |
| T16 | 394-425 | protein_molecule | denotes | 40S ribosomal protein S6 kinase |
| T17 | 463-472 | other_organic_compound | denotes | macrolide |
| T18 | 473-482 | other_organic_compound | denotes | rapamycin |
| T19 | 489-511 | other_organic_compound | denotes | immunosuppressive drug |
| T20 | 532-552 | other_name | denotes | T-cell proliferation |
| T21 | 585-594 | other_organic_compound | denotes | rapamycin |
| T22 | 605-629 | other_name | denotes | T-cell cycle progression |
| T23 | 681-690 | other_organic_compound | denotes | rapamycin |
| T24 | 711-719 | protein_molecule | denotes | p70(s6k) |
| T25 | 724-728 | protein_molecule | denotes | IL-2 |
| T26 | 733-744 | protein_molecule | denotes | PI 3-kinase |
| T27 | 759-763 | protein_family_or_group | denotes | E2Fs |
| T28 | 823-827 | protein_molecule | denotes | IL-2 |
| T29 | 833-844 | protein_molecule | denotes | PI 3-kinase |
| T30 | 884-887 | protein_molecule | denotes | E2F |
| T31 | 998-1007 | other_organic_compound | denotes | rapamycin |
| T32 | 1028-1036 | protein_molecule | denotes | p70(s6k) |
| T33 | 1040-1047 | cell_type | denotes | T cells |
| T34 | 1062-1071 | other_organic_compound | denotes | rapamycin |
| T35 | 1083-1086 | protein_molecule | denotes | E2F |
| T36 | 1108-1117 | other_organic_compound | denotes | rapamycin |
| T37 | 1151-1154 | protein_molecule | denotes | E2F |
| T38 | 1191-1199 | protein_molecule | denotes | p70(s6k) |
| T39 | 1214-1223 | other_organic_compound | denotes | rapamycin |
| T40 | 1234-1242 | protein_molecule | denotes | p70(s6k) |
| T41 | 1260-1269 | other_organic_compound | denotes | rapamycin |
| T42 | 1351-1360 | other_organic_compound | denotes | rapamycin |
| T43 | 1398-1422 | other_name | denotes | T-cell cycle progression |
| T44 | 1459-1467 | protein_molecule | denotes | p70(s6k) |
| T45 | 1488-1491 | protein_molecule | denotes | E2F |
| T46 | 1583-1587 | protein_molecule | denotes | IL-2 |
| T47 | 1599-1610 | protein_molecule | denotes | PI 3-kinase |
| T48 | 1616-1624 | protein_molecule | denotes | p70(s6k) |
| T49 | 1650-1663 | other_name | denotes | G1 checkpoint |
| T50 | 1667-1680 | cell_type | denotes | T lymphocytes |